文献速递心外重症与机械循环支持

心脏植入式电子装置患者心脏手术后的导线并发症

Lead complications after cardiac surgery in patients with cardiac implantable electronic devices.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该全国性巢式病例对照研究纳入1998-2017年丹麦首次植入心脏植入式电子装置且术后6个月无事件的≥18岁患者,最终人群67621例,发现1437例(2.1%)导线相关再手术病例并与42698例对照匹配。心脏手术后6个月内导线并发症风险最高(校正IRR 9.6,95%CI 6.2-14.7),1年时风险接近持平(校正IRR 1.2,95%CI 0.8-1.7)。结论认为心脏手术与新植入装置患者的导线并发症风险相关。

要点

  • 心脏手术后6个月内导线相关再手术风险升高(校正IRR 9.6,95%CI 6.2-14.7)。
  • 术后1年时导线相关再手术相对风险接近持平(校正IRR 1.2,95%CI 0.8-1.7)。
  • 研究人群为首次植入装置后6个月无事件的丹麦≥18岁患者。

核心结论

  • 心脏手术与首次植入心脏植入式电子装置患者的导线并发症风险相关。

研究设计与样本

  • 全国性巢式病例对照研究,源人群为1998-2017年丹麦所有首次植入心脏植入式电子装置的≥18岁患者。
  • 纳入者需在植入后6个月存活且无事件,病例与对照按时间、年龄、性别和装置类型以1:30匹配。
  • 最终人群67621例,识别1437例(2.1%)导线相关再手术病例和42698例对照,采用条件logistic回归估计发病率比(IRR)。

主要发现

  • 心脏手术后6个月内导线并发症风险最高(IRR 9.7,95%CI 6.3-14.8;校正IRR 9.6,95%CI 6.2-14.7)。
  • 心脏手术后1年时导线相关再手术的相对风险接近持平(校正IRR 1.2,95%CI 0.8-1.7)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Manipulation of the heart during cardiac surgery in patients with cardiac implantable electronic devices (CIEDs) may result in lead damage or displacement, but whether cardiac surgery truly infers an excess risk of lead failure is not known. The objective of this study was to examine the risk of lead complications after cardiac surgery in patients with CIEDs. METHODS: We conducted a nationwide nested case-control study. The source population comprised all Danish patients ≥18 of age who underwent a de novo CIED implantation during 1998-2017. For inclusion, patients had to be alive and event free 6 months after implantation. Cases were matched 1:30 to controls on time, age, sex, and device type using risk set sampling. We used conditional logistic regression to estimate incidence rate ratios (IRRs) for the association between cardiac surgery and lead-related reoperation. RESULTS: Our final population consisted of 67 621 patients. We identified 1437 (2.1%) incident cases of lead-related reoperations and 42 698 controls. Risk of lead complications was highest within 6 months of cardiac surgery [IRR 9.7, 95% confidence interval (CI) 6.3-14.8, adjusted IRR 9.6, 95% CI 6.2-14.7], and at 1 year, the relative risk of lead-related reoperation was close to unity (adjusted IRR 1.2, 95% CI 0.8-1.7). CONCLUSIONS: Cardiac surgery was associated with a considerable risk of lead complications in patients with de novo CIEDs.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Frausing MHJP, Nielsen JC, Johansen JB, et al. Lead complications after cardiac surgery in patients with cardiac implantable electronic devices. Eur J Cardiothorac Surg. 2022. PMID: 35639747. doi:10.1093/ejcts/ezac318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。